Titlebook: Stem Cell Therapy for Vascular Diseases; State of the Evidenc Tulio Pinho Navarro,Lara Lellis Navarro Minchillo Book 2021 Springer Nature

陈列

阉割

Changing the Course of Peripheral Arterial Disease Using Adult Stem Progenitor Cells,tion) are transformed, within a day, into a therapeutic product (BGC101) composed of endothelial progenitor cells (EPCs), SPCs, dendritic cells (DCs), and T helper cells. BGC101 was found safe and effective in stabilizing and reversing the course of CLI. Controlled studies on a larger population are

Muscularis

Stem Cell Delivery for the Treatment of Arteriovenous Fistula Failure, a great deal of work aimed at reducing and preventing fistula failure with some benefit. Despite these advances, fistula failure remains a significant problem as only about 60% of fistulas remain patent at one year (Al-Jaishi et al., Am J Kidney Dis 63:464–478, 2014)..Mesenchymal stem cells are plu